Canada · Delayed Price · Currency is CAD Augmedix Statistics
Total Valuation
TSXV:STS has a market cap or net worth of CAD 14.53 million. The enterprise value is 12.70 million.
| Market Cap | 14.53M |
| Enterprise Value | 12.70M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:STS has 60.56 million shares outstanding. The number of shares has increased by 36.60% in one year.
| Current Share Class | 60.56M |
| Shares Outstanding | 60.56M |
| Shares Change (YoY) | +36.60% |
| Shares Change (QoQ) | +12.40% |
| Owned by Insiders (%) | 4.28% |
| Owned by Institutions (%) | 44.81% |
| Float | 54.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.70 |
| P/TBV Ratio | 1.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.71 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.07 |
Financial Position
The company has a current ratio of 0.55
| Current Ratio | 0.55 |
| Quick Ratio | 0.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -182,814.53 |
Financial Efficiency
Return on equity (ROE) is -56.75% and return on invested capital (ROIC) is -39.22%.
| Return on Equity (ROE) | -56.75% |
| Return on Assets (ROA) | -15.48% |
| Return on Invested Capital (ROIC) | -39.22% |
| Return on Capital Employed (ROCE) | -33.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -619,842 |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.36% in the last 52 weeks. The beta is 0.89, so TSXV:STS's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -56.36% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.44 |
| Relative Strength Index (RSI) | 48.66 |
| Average Volume (20 Days) | 22,962 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.60M |
| Operating Income | -8.23M |
| Pretax Income | -7.44M |
| Net Income | -7.44M |
| EBITDA | -8.21M |
| EBIT | -8.23M |
| Earnings Per Share (EPS) | -0.14 |
Balance Sheet
The company has 1.83 million in cash and n/a in debt, giving a net cash position of 1.83 million or 0.03 per share.
| Cash & Cash Equivalents | 1.83M |
| Total Debt | n/a |
| Net Cash | 1.83M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 8.57M |
| Book Value Per Share | 0.14 |
| Working Capital | -2.29M |
Cash Flow
In the last 12 months, operating cash flow was -8.65 million and capital expenditures -3.25 million, giving a free cash flow of -11.90 million.
| Operating Cash Flow | -8.65M |
| Capital Expenditures | -3.25M |
| Free Cash Flow | -11.90M |
| FCF Per Share | -0.20 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:STS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.60% |
| Shareholder Yield | n/a |
| Earnings Yield | -51.18% |
| FCF Yield | -81.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 22, 2022. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jun 22, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |